CCO Management Series

NNRTIs in Clinical Practice: An Update

When to Use NNRTI Agents

Module 1 of 2

Faculty:

William G. Powderly, MD
  • William G. Powderly, MD

CME CREDIT INFORMATION

Release Date: 12/01/06

Expiration Date: 11/30/07


Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.2 Nursing CE credits

Pharmacists: 1.0 contact hour (0.1 CEUs)

Status: Please log in to view status
Begin the Module

William G. Powderly, MD, traces the history of NNRTIs in the treatment of HIV and explores the current clinical use of these antiretroviral drugs.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the results of clinical trials evaluating the efficacy of NNRTI therapy in treatment-naive patients
  • Review factors associated with NNRTI therapies including efficacy and tolerability considerations
  • Discuss guideline recommendations on preferred and alternative first-line antiretroviral regimens

Managing Adverse Effects of NNRTIs

Module 2 of 2

Faculty:

Schlomo Staszewski, MDBrenda Dauer, DC
  • Schlomo Staszewski, MD
  • Brenda Dauer, DC

CME CREDIT INFORMATION

Release Date: 12/13/06

Expiration Date: 12/12/07


Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.1 Nursing CE credits

Pharmacists: 1.0 contact hour (0.1 CEUs)

Status: Please log in to view status
Begin the Module

Schlomo Staszewski, MD and Brenda Dauer, DC, explore the most common adverse effects of the NNRTI agents and review their impact on patient management.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe common short-term adverse effects of the NNRTI agents and their prevalence
  • Review clinical features of NNRTI-related adverse events and review their impact on patient management
  • Discuss data on long-term safety of NNRTI use

Interactive Case Challenges

Management of Adverse Effects in a Woman Switching From Fixed-Dose NRTIs to a DHHS-Recommended Regimen

Faculty:

Paul E. Sax, MD
  • Paul E. Sax, MD

CME CREDIT INFORMATION

Release Date: 12/19/06

Expiration Date: 12/18/07


Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Registered Nurses: 0.75 Nursing CE credits

Status: Please log in to view status
Begin the Case Challenge

Paul E. Sax, MD, reviews how to manage adverse effects associated with antiretroviral substitutions.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe common short-term adverse effects of the NNRTI agents and their prevalence
  • Review clinical features of NNRTI-related adverse events and review their impact on patient management
  • Discuss data on long-term safety and efficacy of NNRTI use

Treatment of a Newly Diagnosed HIV-Infected 24-Year-Old Male With Suboptimal Adherence

Faculty:

John A. Bartlett, MD
  • John A. Bartlett, MD

CME CREDIT INFORMATION

Release Date: 01/09/07

Expiration Date: 01/08/08


Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Registered Nurses: 0.75 Nursing CE credits

Status: Please log in to view status
Begin the Case Challenge

John A. Bartlett, MD, reviews how to best treat a newly diagnosed HIV-infected patient by selecting the most effective first-line regimen and managing adverse events.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss current guidelines and results from recent clinical trials regarding the initiation of antiretroviral therapy
  • Review the importance of resistance testing before treatment initiation and during virologic failure
  • Describe data on the role of adherence and factors affecting it in successful long-term therapy

CCO Slidesets

NNRTIs in Clinical Practice


Format: Microsoft PowerPoint (.ppt) | File size: 587 KB


Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Medical Education Collaborative and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.